Steve E. Krognes, Director at Guardant Health, Inc. (GH), sold 9,294 shares at $132.51 ($1.2M) on 2026-06-04, disclosed to the SEC on 2026-06-05.
Open-market sale of $1.2M GH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DNLI | SELL | 2025-01-03 | $608K | — | Filing → |
| DNLI | SELL | 2024-10-02 | $871K | — | Filing → |
| DNLI | SELL | 2024-08-22 | $41K | — | Filing → |